High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group
about
Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidenceHigh VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology GroupCorrelation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: a report from the Children's Oncology Group.Dynamic chemotherapy-induced upregulation of CXCR4 expression: a mechanism of therapeutic resistance in pediatric AML.The bone marrow microenvironment and leukemia: biology and therapeutic targeting.Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemiaTargeting the microenvironment in acute myeloid leukemia.VLA-4 and CXCR4 expression levels show contrasting prognostic impact (favorable and unfavorable, respectively) in acute myeloid leukemia.The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia.Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment.
P2860
Q26770388-1C0ABD64-C7C3-4C39-A30C-D44D378721DCQ35528643-B02C56C8-0C8E-4650-ABCC-C0A88C9BD4ADQ35862717-5EA17E97-831A-4CFA-803D-A0FEDC8C0A4CQ35909648-508B784D-38D7-4F91-B51C-FFA1AC0B2EB7Q36914445-53B334CA-E6CD-4512-9453-169F416C3B91Q37131922-574A1263-CE52-4663-9546-6B00B5B02B17Q37185272-F005CBF1-A416-4B6D-874D-03EA629CEC57Q37888712-AF8BAA59-0167-44EF-A44A-7844E34D4349Q38068816-2F46165F-F2FC-42D6-BAF6-DBDF9A1C49EDQ38447268-FCD4FD82-8D13-49D4-A05F-ADA939C7F4F3Q41602417-003D6704-C53B-44FB-BF4A-92B4C452FAE3Q49176545-A0932D03-B0B0-4B15-A4D3-5A6E59C9E617Q55712500-EB3047F8-FC60-4D0E-B04F-15E502CD24E4
P2860
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High expression of the very la ...... the children's oncology group
@ast
High expression of the very la ...... the children's oncology group
@en
type
label
High expression of the very la ...... the children's oncology group
@ast
High expression of the very la ...... the children's oncology group
@en
prefLabel
High expression of the very la ...... the children's oncology group
@ast
High expression of the very la ...... the children's oncology group
@en
P2093
P2860
P356
P1476
High expression of the very la ...... the children's oncology group
@en
P2093
Alan S Gamis
Betsy A Hirsch
Craig A Hurwitz
Franklin O Smith
Janet L Franklin
Michael R Loken
Robert B Gerbing
Soheil Meshinchi
Susana C Raimondi
Todd A Alonzo
P2860
P304
P356
10.1200/JCO.2009.27.5693
P407
P577
2010-04-26T00:00:00Z